Anuncio
Anuncio
GTBP
GT Biopharma Inc. Common Stock
0.69
USDPatrocinado
+0.01
+0.74%
09 ene, 15:59 UTC -5
Cerrado
Post-mercado
0.68
-0.01
-0.88%
Informes de beneficios de GTBP
Ratio de Sorpresa Positivo
GTBP superó 11 de las últimas 18 estimaciones.
61%
Próximo informe
Fecha del próximo informe
19 feb 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.22
Cambio implícito desde Q3 25 (Revenue/ EPS)
--
/-72.15%
Cambio implícito desde Q4 24 (Revenue/ EPS)
--
/-86.75%
GT Biopharma Inc. Common Stock earnings per share and revenue
On 14 nov 2025, GTBP reported earnings of -0.79 USD per share (EPS) for Q3 25, missing the estimate of -0.38 USD, resulting in a -103.82% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -25.34% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analistas forecast an EPS of -0.22 USD, with revenue projected to reach -- USD, implying an reducir of -72.15% EPS, and aumentar of 0.00% in Revenue from the last quarter.
Preguntas frecuentes
What were GT Biopharma Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, GT Biopharma Inc. Common Stock reported EPS of -$0.79, missing estimates by -103.82%, and revenue of $0.00, 0% as expectations.
How did the market react to GT Biopharma Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -25.34%, changed from $0.92 before the earnings release to $0.69 the day after.
When is GT Biopharma Inc. Common Stock expected to report next?
The next earning report is scheduled for 19 feb 2026.
What are the forecasts for GT Biopharma Inc. Common Stock's next earnings report?
Based on 3
analistas, GT Biopharma Inc. Common Stock is expected to report EPS of -$0.22 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Cheque FXEmpire's Earnings Calendar for today's list of reporting companies.
Anuncio